Both D- and L-glucose polyphosphates mimic D-myo-inositol 1,4,5-trisphosphate: new synthetic agonists and partial agonists at the Ins(1,4,5)P3 receptor

Shipton, Megan, Riley, Andrew M., Rossi, Ana, Brearley, Charles, Taylor, Colin and Potter, Barry V. L. (2020) Both D- and L-glucose polyphosphates mimic D-myo-inositol 1,4,5-trisphosphate: new synthetic agonists and partial agonists at the Ins(1,4,5)P3 receptor. Journal of Medicinal Chemistry, 63 (10). 5442–5457. ISSN 0022-2623

[img] XML Word Processing Document (DOCX) (SI-1F)
Restricted to Repository staff only until 14 April 2021.

Download (1MB) | Request a copy
[img] PDF (Accepted_Manuscript) - Submitted Version
Restricted to Repository staff only until 14 April 2021.

Download (471kB) | Request a copy
[img] PDF (SI-2F)
Restricted to Repository staff only until 14 April 2021.

Download (4MB) | Request a copy

Abstract

Chiral sugar derivatives are potential cyclitol surrogates of the Ca2+-mobilizing intracellular messenger d-myo-inositol 1,4,5-trisphosphate [Ins(1,4,5)P3]. Six novel polyphosphorylated analogues derived from both d- and l-glucose were synthesized. Binding to Ins(1,4,5)P3 receptors [Ins(1,4,5)P3R] and the ability to release Ca2+ from intracellular stores via type 1 Ins(1,4,5)P3Rs were investigated. β-d-Glucopyranosyl 1,3,4-tris-phosphate, with similar phosphate regiochemistry and stereochemistry to Ins(1,4,5)P3, and α-d-glucopyranosyl 1,3,4-tris-phosphate are full agonists, being equipotent and 23-fold less potent than Ins(1,4,5)P3, respectively, in Ca2+-release assays and similar to Ins(1,4,5)P3 and 15-fold weaker in binding assays. They can be viewed as truncated analogues of adenophostin A and refine understanding of structure-activity relationships for this Ins(1,4,5)P3R agonist. l-Glucose-derived ligands, methyl α-l-glucopyranoside 2,3,6-trisphosphate and methyl α-l-glucopyranoside 2,4,6-trisphosphate, are also active, while their corresponding d-enantiomers, methyl α-d-glucopyranoside 2,3,6-trisphosphate and methyl α-d-glucopyranoside 2,4,6-trisphosphate, are inactive. Interestingly, both l-glucose-derived ligands are partial agonists: they are among the least efficacious agonists of Ins(1,4,5)P3R yet identified, providing new leads for antagonist development.

Item Type: Article
Faculty \ School: Faculty of Science > School of Biological Sciences
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 16 Apr 2020 00:46
Last Modified: 11 Jul 2020 00:09
URI: https://ueaeprints.uea.ac.uk/id/eprint/74760
DOI: 10.1021/acs.jmedchem.0c00215

Actions (login required)

View Item View Item